BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8978340)

  • 21. Mutational analysis of promoters of mismatch repair genes hMSH2 and hMLH1 in hereditary nonpolyposis colorectal cancer and early onset colorectal cancer patients: identification of three novel germ-line mutations in promoter of the hMSH2 gene.
    Shin KH; Shin JH; Kim JH; Park JG
    Cancer Res; 2002 Jan; 62(1):38-42. PubMed ID: 11782355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer.
    Parsons R; Myeroff LL; Liu B; Willson JK; Markowitz SD; Kinzler KW; Vogelstein B
    Cancer Res; 1995 Dec; 55(23):5548-50. PubMed ID: 7585632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathologic and genetic features of nonfamilial colorectal carcinomas with DNA replication errors.
    Senba S; Konishi F; Okamoto T; Kashiwagi H; Kanazawa K; Miyaki M; Konishi M; Tsukamoto T
    Cancer; 1998 Jan; 82(2):279-85. PubMed ID: 9445183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Germline mutations in a polycytosine repeat of the hMSH6 gene in Korean hereditary nonpolyposis colorectal cancer.
    Shin KH; Ku JL; Park JG
    J Hum Genet; 1999; 44(1):18-21. PubMed ID: 9929971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RER phenotype and its associated mutations in familial gastric cancer.
    Shinmura K; Tani M; Isogaki J; Wang Y; Sugimura H; Yokota J
    Carcinogenesis; 1998 Feb; 19(2):247-51. PubMed ID: 9498272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. E2F-4 mutation in hereditary non-polyposis colorectal cancer.
    Moriyama H; Sasamoto H; Kambara T; Matsubara N; Ikeda M; Baba S; Meltzer SJ; Lynch HT; Shimizu K; Tanaka N
    J Exp Clin Cancer Res; 2002 Jun; 21(2):185-9. PubMed ID: 12148576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ATM polymorphism and hereditary nonpolyposis colorectal cancer (HNPCC) age of onset (United States).
    Jones JS; Gu X; Lynch PM; Rodriguez-Bigas M; Amos CI; Frazier ML
    Cancer Causes Control; 2005 Aug; 16(6):749-53. PubMed ID: 16049814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The TGF-beta type II receptor in chronic myeloid leukemia: analysis of microsatellite regions and gene expression.
    Rooke HM; Vitas MR; Crosier PS; Crosier KE
    Leukemia; 1999 Apr; 13(4):535-41. PubMed ID: 10214859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis.
    Young J; Simms LA; Biden KG; Wynter C; Whitehall V; Karamatic R; George J; Goldblatt J; Walpole I; Robin SA; Borten MM; Stitz R; Searle J; McKeone D; Fraser L; Purdie DR; Podger K; Price R; Buttenshaw R; Walsh MD; Barker M; Leggett BA; Jass JR
    Am J Pathol; 2001 Dec; 159(6):2107-16. PubMed ID: 11733361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced expression of cyclooxygenase 2 proteins in hereditary nonpolyposis colorectal cancers relative to sporadic cancers.
    Sinicrope FA; Lemoine M; Xi L; Lynch PM; Cleary KR; Shen Y; Frazier ML
    Gastroenterology; 1999 Aug; 117(2):350-8. PubMed ID: 10419916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells.
    Wang J; Sun L; Myeroff L; Wang X; Gentry LE; Yang J; Liang J; Zborowska E; Markowitz S; Willson JK
    J Biol Chem; 1995 Sep; 270(37):22044-9. PubMed ID: 7665626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analyses of the APC and TGF-beta type II receptor genes, and microsatellite instability in mucosal colorectal carcinomas.
    Yagi OK; Akiyama Y; Ohkura Y; Ban S; Endo M; Saitoh K; Yuasa Y
    Jpn J Cancer Res; 1997 Aug; 88(8):718-24. PubMed ID: 9330602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome.
    Johnson V; Volikos E; Halford SE; Eftekhar Sadat ET; Popat S; Talbot I; Truninger K; Martin J; Jass J; Houlston R; Atkin W; Tomlinson IP; Silver AR
    Gut; 2005 Feb; 54(2):264-7. PubMed ID: 15647192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mean age of tumor onset in hereditary nonpolyposis colorectal cancer (HNPCC) families correlates with the presence of mutations in DNA mismatch repair genes.
    Pensotti V; Radice P; Presciuttini S; Calistri D; Gazzoli I; Grimalt Perez A; Mondini P; Buonsanti G; Sala P; Rossetti C; Ranzani GN; Bertario L; Pierotti MA
    Genes Chromosomes Cancer; 1997 Jul; 19(3):135-42. PubMed ID: 9218993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Human mismatch repair genes and HNPCC].
    Yuasa Y
    Nihon Rinsho; 1996 Apr; 54(4):996-1001. PubMed ID: 8920663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transforming growth factor-beta receptor type 2 mutations and microsatellite instability in sporadic colorectal adenomas and carcinomas.
    Samowitz WS; Slattery ML
    Am J Pathol; 1997 Jul; 151(1):33-5. PubMed ID: 9212728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients.
    Aaltonen LA; Peltomäki P; Mecklin JP; Järvinen H; Jass JR; Green JS; Lynch HT; Watson P; Tallqvist G; Juhola M
    Cancer Res; 1994 Apr; 54(7):1645-8. PubMed ID: 8137274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel missense mutation and frameshift mutations in the type II receptor of transforming growth factor-beta gene in sporadic colon cancer with microsatellite instability.
    Orimo H; Ikejima M; Nakajima E; Emi M; Shimada T
    Mutat Res; 1998 May; 382(3-4):115-20. PubMed ID: 9691992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families.
    Johnson V; Lipton LR; Cummings C; Eftekhar Sadat AT; Izatt L; Hodgson SV; Talbot IC; Thomas HJ; Silver AJ; Tomlinson IP
    J Med Genet; 2005 Oct; 42(10):756-62. PubMed ID: 15788729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis.
    de Leon MP; Pedroni M; Benatti P; Percesepe A; Di Gregorio C; Foroni M; Rossi G; Genuardi M; Neri G; Leonardi F; Viel A; Capozzi E; Boiocchi M; Roncucci L
    Gut; 1999 Jul; 45(1):32-8. PubMed ID: 10369701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.